CYRX Cryoport, Inc.

NEUTRAL Impact: 4/10 Insider Cluster (3 insiders)
Horizon weeks Filed Jun 12, 2026 Processed 8d 9h ago
Insider cluster: 2 insiders, $3.1M total
Latest settled — T+1d
CYRX ▼ -0.81% at T+1d
NEUTRAL call ✗ call lost -0.81% · α vs SPY -0.21% · entry $14.83 → $14.71
Next anchor: T+5d tomorrow
Last close $14.57 (close Jun 17) · -1.75% from $14.83 entry
Entry anchored
Jun 12, 03:59 PM ET
via Databento tick
T+1d
-0.81%
call -0.81% · α -0.21%
$14.71
settled 6d ago
T+5d
call — · α —
tomorrow
T+20d
call — · α —
in 22d
T+60d
call — · α —
in 3mo

Price Chart

Loading chart...

Executive Summary

Two CYRX insiders (CFO and a Director) sold a combined ~$3.12M in open-market shares over a 7-day window, representing ~0.43% of the company's $725M market cap. The CFO's $2.76M sale is the dominant transaction and, while material in absolute terms, falls within the modest-to-noteworthy proportionality band. The cluster is a sell-only event with no offsetting insider purchases, but the sales appear to be part of a regular pattern (likely 10b5-1 or vesting-related), reducing their informational value. The historical calibration shows past neutral reports on CYRX have been followed by strong positive returns, suggesting the market may not view insider selling as a negative signal for this stock.

Key Financial Metrics

Direction
selling
Total Value
$3.1M
Insiders
3

Actionable Insight

The CFO's large sale is notable but likely part of a pre-arranged 10b5-1 plan or routine diversification. Given the strong historical positive drift after past neutral reports on CYRX, this cluster alone does not warrant a bearish stance. Monitor for any subsequent insider purchases or a material change in business fundamentals (e.g., upcoming earnings or guidance) that could validate or refute the selling signal.

Key Facts

  • CFO Robert Stefanovich sold 169,400 shares at ~$16.27 for $2.76M on 2026-06-04
  • Director Ramkumar Mandalam sold 23,214 shares at ~$15.44 for $358K on 2026-06-08
  • Total open-market sales: ~$3.12M, or ~0.43% of $725M market cap
  • No insider purchases in the cluster window
  • Past CYRX reports (all neutral) have been followed by +29% avg T+20 return, suggesting insider selling may not be a bearish signal here

Financial Impact

~$3.12M in insider sales, ~0.43% of market cap

insider ownershipfloat

Risk Factors

  • CFO selling a large stake could signal reduced confidence in near-term prospects
  • No insider buying to offset the selling creates a one-sided negative signal
  • If the sales are not part of a 10b5-1 plan, they may carry more informational weight

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (16 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CYRX-1781303913757
3 reports for CYRX
Performance horizon
Filters
Rows
Reports for CYRX — sortable, filterable
Type Now
Jun 12, 2026
8d ago
Insider Cluster
NEUTRAL ★ 4/10
$14.83 $14.71▼ −0.81%▼ −0.21%$14.57 (−1.75%)
Mar 16, 2026
13w ago
Insider Cluster
NEUTRAL ★ 3/10
$8.00 $8.36▲ +4.50%▲ +4.23%$14.57 (+82.12%)
Mar 16, 2026
13w ago
Insider Cluster
NEUTRAL ★ 4/10
$8.00 $8.36▲ +4.50%▲ +4.23%$14.57 (+82.12%)
Showing 3 of 3

US Market Status

Market Closed — Opens Mon (29h 32m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access